David Voris

Chief Financial Officer

Therapeutic Areas

Drug	Indication	Phase
Next Generation pVAD	Temporary mechanical circulatory support for High-Risk Percutaneous Coronary Intervention (PCI) and Cardiogenic Shock (CS)	Pivotal